Capstone Holding Corp. (CAPS) vs Arcadia Biosciences, Inc. (RKDA)

A side-by-side comparison of Capstone Holding Corp. and Arcadia Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CAPS vs RKDA

growth of $100 · dividends reinvested · last 10y
CAPS -99.5% (-41.4%/yr)RKDA -100.0% (-57.7%/yr)CAPS compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020182020202220242026$0$0
CAPS RKDA

CAPS vs RKDA: by the numbers

  • •CAPS is the larger company ($2M vs $445782 market cap).
  • •Both run net losses; CAPS's is the smaller (-36.68% vs -234.53% net margin).
  • •CAPS grew revenue faster over the past five years (0.62% vs -13.28% CAGR).

Metrics side by side

Valuation

MetricCAPSRKDA
P/S ratio0.040.09
P/B ratio0.170.70

Profitability

MetricCAPSRKDA
Gross margin25.40%34.58%
Operating margin-6.00%-205.74%
Net margin-36.68%-234.53%
ROE-177.91%-1758.45%
ROIC-11.35%-95.57%

Growth (annualized)

MetricCAPSRKDA
Revenue CAGR (5Y)0.62%-13.28%
Total return CAGR (5Y)-58.05%-67.74%

Frequently asked

Which has grown faster, CAPS or RKDA?
Over the past five years, CAPS grew revenue faster — CAPS at a 0.62% CAGR versus RKDA at -13.28%.
How have CAPS and RKDA total returns compared?
Over the past 10 years, CAPS delivered -41.42% and RKDA delivered -57.70% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.